Prospective allometric scaling: Does the Emperor have clothes?

Journal of Clinical Pharmacology

Volumn 40, Issue 4, 2000, Pages 341-344

  Mahmood, I ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOMETRY; DOSE CALCULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; NOTE; PREDICTION; ANIMAL; BODY WEIGHT; BRAIN; HALF LIFE TIME; HISTOLOGY; HUMAN; LONGEVITY; METABOLIC CLEARANCE RATE; ORGAN SIZE; PHARMACOKINETICS; TISSUE DISTRIBUTION;

ANIMALS; BODY WEIGHT; BRAIN; HALF-LIFE; HUMANS; LONGEVITY; METABOLIC CLEARANCE RATE; ORGAN SIZE; PHARMACOKINETICS; TISSUE DISTRIBUTION;

EID: 0033638257     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700022009026     Document Type: Note

References (17)

1. Prospective allometric scaling: Does the emperor have clothes?
2. Pharmacokinetics of susalimod, a highly biliary-excreted sulphasalazine analogue, in various species: Nonpredictable human clearance by allometric scaling
3. Interspecies pharmacokinetic comparisons and allometric scaling of napsagatran, a low molecular weight thrombin inhibitor
4. Interspecies scaling of renally secreted drugs
5. Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm
6. Interspecies scaling: Predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance
7. A new extrapolation method from animal to man: Application to a metabolized compound, mofarotene
8. Interspecies scaling: Predicting clearance of drugs in humans: Three different approaches
9. Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: Application to 10 extensively metabolized drugs
10. Interspecies scaling: Predicting volumes, mean residence time and elimination half-life: Some suggestions
11. Predicting toxicokinetic parameters in humans from toxicokinetic data acquired from three small mammalian species
12. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism
13. An evaluation of the integration of pharmacokinetics and pharmacodynamic principles in clinical drug development: Experience with Hoffman La-Roche
14. First time in human for GV196771: Interspecies scaling applied on dose selection
15. The metabolism and pharmacokinetics of amlodipine in humans and animals
16. Pharmacokinetics and metabolism of dofetilide in mouse, rat, dog and man
17. Comparative pharmacokinetics of nicardipine hydrochloride, a new vasolidator, in various species